Heliae Expands Global Footprint with First Joint Venture in Japan
Heliae partners with Sincere Corporation for algae production venture to meet Japanese market demand for sustainable ingredients

Gilbert, Ariz. (July 1, 2014) – Heliae, a leader in the development of advanced algae production technologies, today announced a partnership with Japan-based Sincere Corporation, a waste management and recycling company, to form a joint venture and develop a commercial algae production facility in Saga City, Japan. The joint venture has been named Alvita Corporation, and will combine Sincere Corporation’s operational skill, distribution networks and knowledge of the Japanese market with Heliae’s proprietary algae production technology to supply natural astaxanthin, a powerful antioxidant with broad health benefits, to the growing health and wellness market in the region.

Heliae develops advanced algae strains, production technology, and downstream processing equipment to optimize algae production for a range of product targets in the nutrition, therapeutics, agrosciences, health & beauty and specialty chemicals and fuels fields. It’s backed by, among others, the Mars family.

Heliae offers clients access to its library of wild and enhanced algae strains, each selected and honed for key attributes to offer a wide range of product and service functionality. Heliae offers a series of commercially-validated algae production systems — including strain screening, in-situ mobile pilot systems, seed production units, and the Volaris production platform.

In January 2014, Heliae Development had booked $4.2 million in sales for their raceway-based algae growing technology, after completing a $13 million demonstration plant. Although the company has equipment on site to develop fuels from the algae, and the company has previously turned algae into jet fuel on site, Heliae is focusing on the growing side of the equation. The company brought in more than $1 million in revenue last year.

In April 2013, Heliae is announcing the launch of its new microalgae production platform, Volaris.  Deployment of the Volaris platform will support commercial activities in Heliae’s target markets including nutrition, therapeutics, health & beauty, and agrosciences. The company said that Volaris will play an important role in Heliae’s new 20-acre commercial facility currently under construction in Gilbert, Ariz., slated to open in late Q3 of 2013.